• Title/Summary/Keyword: radiopharmaceutical

Search Result 156, Processing Time 0.02 seconds

Lung Perfusion Imaging and $Tc^{99m}-Macroaggregated$ Human Serum Albumin

  • Haider, Kh.H.;Ilyas, M.;Hyder, Q.;Kim, Chong-Kook
    • Journal of Pharmaceutical Investigation
    • /
    • v.31 no.2
    • /
    • pp.73-80
    • /
    • 2001
  • Lung perfusion scanning, invariably combined with ventilation studies provides a reliable and non-invasive mean to diagnose lung related pathologies despite the availability of modern techniques such as angiography, magnetic resonance imaging, magnetic resonance angiography, and helical (spiral) computed tomography. The technique involves the generation of images by radiations emitted from radioisotopes introduced in to the lungs. Various radiopharmaceuticals have been proposed and designed to incorporate $Tc^{99m}$ in to macroparticulate form for lung perfusion imaging. However, most of these have associated difficulties such as reproducibility of the product with regards to particle size distribution and poor elimination from the lung capillary bed. $Tc^{99m}$ macroaggregated albumin $(Tc^{99m}-MAA)$ is used extensively for clinical lung perfusion imaging and is considered as the radiopharmaceutical of choice. It is non-toxic, safe, and being biodegradable, is easily eliminated from the lung capillary bed by proteolytic enzyme metabolism and by mechanical forces due to lung movement.

  • PDF

Preparation of Radiopharmaceuticals (IV) Quality Control and Chemical Analysis of Radiopharmaceuticals (방사성의약품 합성 방식에 관한 연구 제4보 방사성의약품의 품질관리 및 안정도 시험)

  • Kim, You-Sun;Kim, Tae-Young
    • The Korean Journal of Nuclear Medicine
    • /
    • v.4 no.1
    • /
    • pp.51-60
    • /
    • 1970
  • In 1969 this laboratory had prepared 131 mc. of radiopharmaceuticals in total (Hippuran and other four kinds) and distributed to the major medical establishments. The quality and stability of these products were reviewed by means of radio paper partition chromatography and thin layer chromatography and results were compared to those of foreign products. Generally, the quality and stability of the product of this laboratory were better than those of the foreign product, even though the properties of the radiopharmaceutical were varied by the procedure of the preparation adopted. Various precautions for handling radiopharmaceuticals for clinical use were also described with a view of quality control and stability test there of.

  • PDF

A Study on Radiologic Technologist's License System and Primary Pathway Education Curriculum in the United States American : Focused on One Case of College in Texas (미국 방사선사 면허제도와 기본 교육과정에 대한 고찰 : 텍사스주 일개 대학 사례를 중심으로)

  • Seoung, Youl-Hun
    • Journal of radiological science and technology
    • /
    • v.43 no.1
    • /
    • pp.35-43
    • /
    • 2020
  • The purpose of this study was to study on radiologic technologist's license system and primary pathway education curriculum in the United States American (USA), focused on one case of college in Texas. We were collected and analyzed through class participation at a community college in Tarrant, interviews with professors of radiologic science and clinical radiographers, field trips, an internet search, and literature reviews. As a result, first, the American radiologic technologists license system is composed of fifteen chapters, and the professional education courses for each field are being carried out through three courses of a primary pathway, a post primary pathway and a physician extender. Second, the primary pathway courses consisted the radiography, the radiation therapy, the nuclear medicine, the magnetic resonance imaging, the sonography. Third, the USA had about 30 times more clinical practice time than Korea. In clinical practice, students had done actually examination through X-ray exposure on patients. Last radiographers in the USA was able to perform intravenous injection of radiopharmaceutical agents on patient, so that he could perform rapid examination and efficient manpower operation. This study could be used as basic data for the globalization of radiologic technologists license system in Korea.

Pretargeting : A concept refraining traditional flaws in tumor targeting

  • Bhise, Abhinav;Yoo, Jeongsoo
    • Journal of Radiopharmaceuticals and Molecular Probes
    • /
    • v.6 no.1
    • /
    • pp.53-58
    • /
    • 2020
  • Pretargeting is a two-component strategy often used for tumor targeting to enhance the tumor-to-background ratio in cancer diagnosis as well as therapy. In the multistep strategy, the highly specific unlabeled monoclonal antibodies (mAbs) with the reactive site is allowed to get localized at tumor site first, and then small and fastclearing radiolabeled chelator with counter reactive site is administered which covalently attaches to mAbs via inverse electron demand Diels-Alder reaction (IEDDA). The catalyst-free IEDDA cycloaddition reaction between 1,2,4,5-tetrazines and strained alkene dienophiles aid with properties like selective bioconjugation, swift and high yielding bioorthogonal reactions are emergent in the development of radiopharmaceutical. Due to its fast pharmacokinetics, the in vivo formed radioimmunoconjugates can be imaged at earlier time points by short-lived radionuclides like 18F and 68Ga; it can also reduce radiation damage to the normal cells. Ultimately, this review elucidates the updated status of pretargeting based on antibodies and IEDDA for tumor diagnosis (PET and SPECT) and therapy.

Diffuse Bone Marrow Uptake of $^{99m}$Tc-MIBI in A Case of Intravascular Large B-cell Lymphoma (혈관내 B 대세포 림프종 환자에서 발견된 $^{99m}$Tc-MIBI의 미만성 골수 섭취)

  • Moon, Seung-Hwan;Oh, So-Won;Paeng, Jin-Chul;Paik, Jin-Ho;Lee, Dong-Soo
    • Nuclear Medicine and Molecular Imaging
    • /
    • v.43 no.4
    • /
    • pp.352-356
    • /
    • 2009
  • Intravascular large B-cell lymphoma (IVLBCL) is a subtype of diffuse large cell lymphoma, characterized by proliferation of lymphoid cells in the intravascular space of various organs without causing a mass effect. Although $^{18}$F-FDG PET is a powerful imaging tool in lymphoma, the usefulness of $^{18}$F-FDG PET in the assessment of IVLBCL is still controversial. $^{99m}$Tc-MIBI, a tumor imaging radiopharmaceutical with a different mechanism from that of $^{18}$F-FDG, has been reported to be also effective in lymphoma. However, there is nearly no report on the efficacy of $^{99m}$Tc-MIBI in the assessment of IVLBCL. We present one case of IVLBCL that showed $^{99m}$Tc-MIBI accumulation in the involved bone marrow as an incidental finding, which was discrepant from that of $^{18}$F-FDG PET.

Development of Radiopharmaceutical DW-166HC for Anticancer drug

  • Man, Ryu-Jei
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1999.04a
    • /
    • pp.53-61
    • /
    • 1999
  • Radiation therapy has been used for the cancer treatment and radiation synovectomy$\^$1-3)/. There are two kinds of radiation therapy; the external radiation therapy and the internal radiation therapy. Hitherto, the external radiation therapy has been widely used, but for the lack of its selectivity it requires strong radiation dose and causes the irritation and damage of the normal tissue or organ. Therefore many researchers give their interests to the internal radiation therapy in which the radioactive materials are injected directly into the target organ or tissue. Many ${\beta}$-emitting radionuclides have been studied for the application of the internal radiation theraily. Among them, Holmium-166 has the many beneficial physical characteristics for the internal radiation therapy such as appropriate half life (26.8hr), high ${\beta}$ energy (max. 1.85 MeV(51%), 1.77 MeV (48%), mean 0.67MeV), and low ${\gamma}$ energy (0.081MeV) easily detected by ${\gamma}$-camera. In the internal radiation therapy, the administered radioactive materials should be retained in the target long enough to increase the therapeutic effects and avoid the damage in the normal tissue or organ. For this purpose, radionuclides are used as complex form with carriers. Carriers should have a high affinity with radionuclides in vivo and in vitro, so the complex can be evenly distributed in the lesion but can not be leaked out from the lesion.

  • PDF

Facile Synthesis and Radioiodine Labeling of Hypericin

  • Kim, Sang-Wook;Park, Jeong-Hoon;Yang, Seung-Dae;Hur, Min-Goo;Kim, Yu-Seok;Chai, Jong-Seo;Kim, Young-Soon;Yu, Kook-Hyun
    • Bulletin of the Korean Chemical Society
    • /
    • v.25 no.8
    • /
    • pp.1147-1150
    • /
    • 2004
  • Hypericin (1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione), an antidepressant which is also known to be a potent protein kinase C (PKC) inhibitor was synthesized as a precursor for radioiodine labeling via two step reactions. Malignant glioma cells express higher PKC activity compared to untransformed glial cell. Here we report the synthesis and radioiodine labeling of hypericin as a potential brain tumor imaging radiopharmaceutical. The reference compound, 2-iodohypericin, and its radiolabelled analogues, 2-[$^{123}I$]iodohypericin and 2-[$^{124}I$]iodohypericin have been prepared by the reaction of hypericin with NaI or [$^{123}I$]NaI or [$^{124}I$]NaI. The labeling yield was 60-65% for each analogue and the optimal reaction time was 10 min. The purification and isolation of the labelled products were achieved by a reversed-phase HPLC.

Synthesis of 18F Labelled Isoquinoline Salt for PET Imaging (PET 영상용 18F 표지 Isoquinolinium Salt의 합성)

  • Kim, Hee Jung;Kim, Dong Yeon;Kim, In Jong;Park, Jeong Hoon;Lee, Heung Nae;Kim, Sang Wook;Hur, Min Goo;Choi, Sang Moo;Yang, Seung Dae;Yu, Kook Hyun
    • Journal of Radiation Industry
    • /
    • v.4 no.1
    • /
    • pp.1-6
    • /
    • 2010
  • The purpose of this study is to synthesize the radio fluorine labelled isoquinoline salt derivative as new radiopharmaceutical for imaging tumors using positron emission tomography (PET). The planarity of isoquinoline allows to inhibit topoisomerase or intercalate between adjacent DNA base pairs, which result in producing double strand breaks in the DNA and a cell death. Therefore, the isoquinoline has seemed to have a potential anticancer activity. In order to obtain 2-(5-[$^{18}F$]fluoropentylisoquinolinium salt with good radiochemical yield, tosylated precursors have been synthesized. The labelling reaction was carried out for 30 minute in HMPA at $120^{\circ}C$. The radiochemical yield was about 50~60%.

Development of Dual FDG Auto Synthesis Module (듀얼 FDG 자동합성장치 개발)

  • Jeong, Cheol-Ki;Lee, Goung-Jin;Hur, Min-Goo;Jang, Hong-Suk;Min, Young-Don
    • Journal of Radiation Industry
    • /
    • v.5 no.4
    • /
    • pp.313-316
    • /
    • 2011
  • [$^{18}F$]FDG (2-[$^{18}F$] Fluoro-2-deoxy-D-Glucose), which is required Automated Synthetic Module for production, is most often used Radiopharmaceuticals in nuclear medicine. In this study, an Automated Synthesis Module was developed to produce FDG in two consecutive time when F-18 feds continuously by modifying a domestic FDG Automated Synthetic Module on structural geometry and control system. The results were showed that the Average Synthesis Yields on the developed Automated Synthetic Module were $45{\pm}3%$ (n=20), $50{\pm}3%$ (n=20) respectively. The Quality Control results, such as Radio TLC, Radiochemical purity, Gamma-counter, pH, LAL Test, Micro bacteria test, showed in same level with domestic [$^{18}F$]FDG Auto-Synthetic modules. Therefore, if some features were improved by considering the components life time and appearance, commercial sales can be expected because of low price and easy maintenance compared with foreign products.

Development of an Automated System for the Routine Preparation of Carbon-11 Labeled Radiopharmaceuticals

  • 오승준;최연성;최용;김상은;이경한;김병태;김영서;하현준
    • Bulletin of the Korean Chemical Society
    • /
    • v.19 no.9
    • /
    • pp.952-956
    • /
    • 1998
  • An automated system was developed for the routine preparation of carbon-11 ($^11C$) labeled radiopharmaceuticals, which consisted of three major parts including [$^11C$]methylation of the precursor with [$^11C$] iodomethane ($[^11C]CH_3I)$, purification of the desired product and formulation of the final $^11C$ labeled radiopharmaceutical. The whole system included seven three-way slider valves, eleven solenoid valves, four pneumatic cylinders, a HPLC (High Performance Liquid Chromatography) system and a rotary evaporator. Using this system, we investigated the radiochemical synthesis of L-[$methyl-^11C$]methionine, which is the most widely used amino acid in tumor PET (Positron Emission Tomography) studies. The overall operation took 3035 min including the production of $[^11C]CH_3I$ (10.5 min) and decay-corrected radiochemical yield was 25%. The automated system we described herein can be widely utilized for the preparation of many $^11C$ labeled radiopharinaceuticals and has been shown to be efficient, reliable and easy to operate.